evertex fabrinology limited

TWSE:1470.TW

23.3 (TWD) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Revenue 655.221845.152894.789630.757818.166754.462701.061685.778761.731744.311669.101696.712789.031811.037709.451
Cost of Revenue 525.403670.834703.668517.086603.76586.4550.707531.084594.712584.971575.638629.066684.531686.178591.249
Gross Profit 129.818174.318191.121113.671214.406168.062150.354154.694167.019159.3493.46367.646104.5124.859118.202
Gross Profit Ratio 0.1980.2060.2140.180.2620.2230.2140.2260.2190.2140.140.0970.1320.1540.167
Reseach & Development Expenses 000000000000000
General & Administrative Expenses 29.42430.76433.85933.26443.43539.6240.05937.02431.17129.73424.25121.9323.68421.30219.784
Selling & Marketing Expenses 67.19175.16678.8261.94484.81476.92672.86769.85566.69458.73649.01943.51340.53342.95239.83
SG&A 96.615105.93112.67995.208128.249116.546112.926106.87997.86588.4773.2765.44364.21764.25459.614
Other Expenses -95.374-19.053-1.135-0.903-0.026.137.1211.1143.1795.1255.3073.3452.1244.1593.047
Operating Expenses 95.374105.93111.54494.305128.229115.675110.946102.48797.4386.5662.01265.44364.21764.25459.614
Operating Income 34.44450.56979.241.74394.33952.38739.40852.20769.58972.7831.4512.20340.28360.60558.588
Operating Income Ratio 0.0530.060.0890.0660.1150.0690.0560.0760.0910.0980.0470.0030.0510.0750.083
Total Other Income Expenses Net 22.734-0.568-0.451-0.912-0.6458.8559.6934.3255.4617.3825.30715.49110.08210.1723.653
Income Before Tax 57.17850.00178.74940.83193.69461.24249.10156.53275.0580.16236.75817.69450.36570.77762.241
Income Before Tax Ratio 0.0870.0590.0880.0650.1150.0810.070.0820.0990.1080.0550.0250.0640.0870.088
Income Tax Expense 7.83217.15813.5485.41717.83312.3757.2679.57613.94913.7957.4582.9178.57913.8678.88
Net Income 49.34632.84365.20135.41475.86148.86741.83446.95661.10166.36729.314.77741.78656.9153.361
Net Income Ratio 0.0750.0390.0730.0560.0930.0650.060.0680.080.0890.0440.0210.0530.070.075
EPS 0.580.380.760.410.880.570.490.550.710.770.340.170.490.660.62
EPS Diluted 0.570.380.760.410.880.570.490.550.710.770.340.170.490.660.62
EBITDA 108.284103.249135.15591.437142.604114.75886.55498.479116.023121.33880.82743.89897.958116.602106.488
EBITDA Ratio 0.1650.1220.1510.1450.1740.1520.1230.1440.1520.1630.1210.0630.1240.1440.15